Management of Persistent Diarrhea

Assessment and Treatment

The American Society of Clinical Oncology recommends ruling out infectious causes through stool culture before escalating therapy, especially if fever or signs of sepsis are present 1, 2
Evaluation for potential causes of persistent diarrhea, including medication-induced diarrhea (chemotherapy, antibiotics), is recommended by the European Society for Medical Oncology 2, 3
The National Comprehensive Cancer Network suggests considering lactose intolerance, which may develop during treatment, as a potential cause of persistent diarrhea 2
Octreotide, at a dosage of 500 μg subcutaneously three times daily, is recommended as a second-line treatment option for persistent diarrhea, with strong evidence supporting its use (Strength of Recommendation: B, Quality of Evidence: II) 2
Adding codeine, 30 mg twice daily, in addition to loperamide, is a recommended second-line treatment option, particularly useful for short-term management 3
Budesonide, 3 mg three times daily, is a recommended alternative option, particularly for inflammatory causes, according to the American Gastroenterological Association 1, 2

Reducing intake of spicy foods, caffeine, alcohol, and high-fat foods is recommended by the Academy of Nutrition and Dietetics 3
Considering a low-fiber diet during acute episodes is suggested by the American College of Gastroenterology 3
Temporarily restricting dairy products, except yogurt and firm cheeses, is recommended if lactose intolerance is suspected, according to the National Institute of Diabetes and Digestive and Kidney Diseases 1
Hospitalization for intravenous fluid replacement is recommended if dehydration occurs despite second-line therapy, as suggested by the Society of Hospital Medicine 1, 3

The American Society of Clinical Oncology recommends that when first-line antimotility agents fail, a different therapeutic approach is needed, with octreotide considered as the next treatment option 4, 5
Before escalating therapy, infectious causes should be excluded through stool culture, and if fever or signs of sepsis are present, consider empiric antimicrobial therapy after appropriate cultures 6, 7

Octreotide is recommended as the first choice for refractory diarrhea, starting with 500 μg subcutaneously three times daily, with strong evidence supporting its use (Strength of Recommendation: B, Quality of Evidence: II) 4, 5
Alternative options include psyllium seeds, codeine, and other opiates, with a strength of recommendation of B and quality of evidence of II or III 4, 7, 8

For patients with cancer-related diarrhea not responding to standard therapy, octreotide has shown significant benefit, according to the National Comprehensive Cancer Network 4, 9
If lactose intolerance is suspected, dietary restriction of milk products should only be implemented if clinical symptoms are present after ingestion, as recommended by the American Gastroenterological Association 5, 7

Monitor for resolution of symptoms and potential side effects of new treatments, and be alert for signs of dehydration and electrolyte imbalances, as recommended by the Journal of the National Comprehensive Cancer Network 8, 9